Orphan Australia Report issue

For profit Phase 4
Founded: Dandenong Australia (1994)
Status: Acquired by Sigma Healthcare (2009)

Organization Overview

First Clinical Trial
2005
NCT00114465
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Crohn Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 9